Ariel Pablos-Mendez on the past, present, and future of TB research and the TB Alliance
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which birthed TB Alliance. Throughout the […]
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which birthed TB Alliance. Throughout the […]
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected
Throughout 2024, one of TB Alliance’s foremost priorities has been ensuring that pretomanid and BPaL-based regimens reach all people with
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
NEW YORK (December 9, 2024)—TB Alliance welcomes Srishti Gupta, MD, MPP, MPhil, and Akshay Vaishnaw, MB, BCh, PhD, FRCP, to
NEW YORK (November 6, 2024) — Macleods, a pharmaceutical company headquartered in India, has received prequalification from the World Health
New York (October 7, 2024) – TB Alliance is proud to announce a $7.35 million award through the U.S. Department
MANILA (September 3, 2024) – A delegation of experts from Brazil’s National TB Program visited Manila recently to collaborate with
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was initiated to explore the use
NEW YORK (August, 15, 2024)—TB Alliance is honored to appoint Ann Taylor, MD to its Board of Directors. Welcoming Dr.